Search
for
Sort by
Research 571–600 of 1000+
- Adverse health effects of androgen use
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- New treatments for rheumatoid arthritis
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Androgens and hair: a biological paradox
- Current standards in the diagnostics and therapy of hair diseases - hair consultation
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Association of Polycystic Ovarian Syndrome (PCOS) With Vaginal Microbiome Dysbiosis: A Scoping Review
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Clinical use of 5α-reductase inhibitors
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Exploring phytoandrogens: A review of their potential in health and medicine
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- A brief report on PCOS: and its inducing model
- Androgen excess: a hallmark of polycystic ovary syndrome
- Hair Loss in Women
- Testosterone and female sexuality: A skeptical view
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Un nuevo anovulador antiandrogénico
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Azelaic Acid: Mechanisms of Action and Clinical Applications